Insider · CIK 0001378550
Richard E Lowenthal
ceopresidentofficerdirectorowner
Files at SPRY (ARS Pharmaceuticals, Inc.). First filing Oct 17, 2024, latest Dec 19, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $7.1M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SPRY: ARS Pharmaceuticals, Inc.
SPRYOct 9, 2026 · close 4.23
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | ARS Pharmaceuticals, Inc. | $1.2M 100,000 shares | -7% | - | |
| 45Moderate | ARS Pharmaceuticals, Inc. | $1.3M 100,000 shares | -8% | - | |
| 45Moderate | ARS Pharmaceuticals, Inc. | $1.4M 100,000 shares | -7% | - | |
| 45Moderate | ARS Pharmaceuticals, Inc. | $1.7M 100,000 shares | -7% | - | |
| 45Moderate | ARS Pharmaceuticals, Inc. | $1.5M 100,000 shares | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | SPRY ARS Pharmaceuticals, Inc. | AGrant or award Stock option (right to buy)derivative | +767,600 | $0.00 | $0 | 767,600 | Jan 3, 2025 |
| Jan 2, 2025 | SPRY ARS Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivativeindirect: By Spouse | +261,900 | $0.00 | $0 | 261,900 | Jan 3, 2025 |
| Dec 17, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 202010b5-1 | -50,000 | $11.67 | $584k | 1,297,447 | Dec 19, 2024 |
| Dec 17, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/200610b5-1 | -50,000 | $11.67 | $584k | 1,098,499 | Dec 19, 2024 |
| Dec 10, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 202010b5-1 | -50,000 | $13.17 | $658k | 1,246,494 | Dec 11, 2024 |
| Dec 10, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/200610b5-1 | -50,000 | $13.16 | $658k | 1,148,499 | Dec 11, 2024 |
| Dec 6, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stock | +11,876 | $8.42 | $100k | 4,327,189 | Dec 9, 2024 |
| Dec 6, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stockindirect: By Spouse | +13,789 | $1.44 | $20k | 3,421,636 | Dec 9, 2024 |
| Dec 6, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stockindirect: By Spouse | +11,876 | $8.42 | $100k | 3,433,512 | Dec 9, 2024 |
| Dec 6, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (right to buy)derivative | -11,876 | $0.00 | $0 | 1,088,124 | Dec 9, 2024 |
| Dec 6, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (right to buy)derivativeindirect: By Spouse | -13,789 | $0.00 | $0 | 20,684 | Dec 9, 2024 |
| Dec 6, 2024 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (right to buy)derivativeindirect: By Spouse | -11,876 | $0.00 | $0 | 338,124 | Dec 9, 2024 |
| Nov 19, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 202010b5-1 | -50,000 | $13.95 | $698k | 1,347,447 | Nov 21, 2024 |
| Nov 19, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/200610b5-1 | -50,000 | $13.95 | $697k | 1,198,499 | Nov 21, 2024 |
| Nov 12, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 202010b5-1 | -45,045 | $16.76 | $755k | 1,301,449 | Nov 14, 2024 |
| Nov 12, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 202010b5-1 | -4,955 | $17.64 | $87k | 1,296,494 | Nov 14, 2024 |
| Nov 12, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/200610b5-1 | -45,124 | $16.76 | $756k | 1,253,375 | Nov 14, 2024 |
| Nov 12, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/200610b5-1 | -4,876 | $17.64 | $86k | 1,248,499 | Nov 14, 2024 |
| Oct 15, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 202010b5-1 | -48,550 | $14.86 | $722k | 1,398,897 | Oct 17, 2024 |
| Oct 15, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 202010b5-1 | -1,450 | $15.25 | $22k | 1,397,447 | Oct 17, 2024 |
| Oct 15, 2024 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/200610b5-1 | -50,000 | $14.88 | $744k | 1,298,499 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.